Inhibrx (INBX) Event Aug. 08, 2022, 20:19 UTC (30% Negative) INHIBRX, INC. (INBX) Reports Q3 2022 Financial Results Full text
Register to leave comments News bot Oct. 2, 2025, 11:25 p.m. 📋 INHIBRX, INC. (INBX) - Financial Results Filing Date: 2022-08-08 Accepted: 2022-08-08 16:19:10 Event Type: Financial Results Event Details: Inhibrx (INBX) Reports Q3 2022 Financial Results Inhibrx (INBX) announced its financial results for the period ending Q3 2022. Key Financial Highlights: Revenue: 711 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: 176385 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2021 2020 Change ($) Change (%) Loss From Operations -19.80K -63.61K $43.81K +68.87% Total Other Income Expense -909.00 -5.37K $4.46K +83.07% Net Loss -20.71K -20.71K $0.00 +0.00% Net Loss Per Share -0.55 -0.55 $0.00 +0.00% Revenue 711.00 711.00 $0.00 +0.00% Loss from Operations -34.60K -19.80K $-14.80K -74.72% Net Loss -37.73K -37.73K $0.00 +0.00% 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: InhibrxCIK: 0001739614Ticker Symbol: INBXPeriod End Date: 2022-08-08Document Type: 8-K
📋 INHIBRX, INC. (INBX) - Financial Results
Filing Date: 2022-08-08
Accepted: 2022-08-08 16:19:10
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: